Report Overview 

The Dental Biomaterials Market is expected to grow at a CAGR of 5.7% during the forecast period 2024-2031 

Dental biomaterials are specialized products, either natural or synthetic, that are engineered for use in preventive and restorative dentistry. They serve the purpose of repairing damaged, decayed, or fractured teeth. Known for their efficiency and high success rate in oral treatment and prevention, these biomaterials replace damaged or missing tooth tissues and aid in tissue regeneration. The category of natural biomaterials encompasses enamel, dentin, cementum, bone, and other intraoral tissues. On the other hand, synthetic materials comprise metals, ceramics, polymers, and composite structures. 

 

Market Segmentation 

By Product 

  • Bone Graft Materials 

  • Dental Membranes 

  • Soft Tissue Regeneration Products 

By Type 

  • Metallic 

  • Ceramic 

  • Natural Dental Biomaterials 

By Application 

  • Implantology 

  • Periodontology 

  • Prosthodontics 

  • Orthodontics 

  • Others 

By End User 

  • Dental implant and prosthetic manufacturers 

  • Dental laboratories 

  • Dental hospitals and clinics 

Dental Biomaterials Market Key Player 

Major players are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante. 

 

Trending Reports